Vir Biotechnology, Inc.VIRNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank75
3Y CAGR-40.8%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-40.8%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202520.29%
202414.20%
2023-182.14%
202298.00%
2021241.68%
2020-66.86%
2019-49.95%
2018-45.64%
20170.00%